Journal of Attention Disorders

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Register here to gain access to SAGE's 500+ Journals Online

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Faries, D. E.
Right arrow Articles by Heiligenstein, J. H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Faries, D. E.
Right arrow Articles by Heiligenstein, J. H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Attention Disorders, Vol. 5, No. 2, 107-115 (2001)
DOI: 10.1177/108705470100500204

Validation of the ADHD Rating Scale as a clirlician administered and scored instrument

Douglas E. Faries

Eli Lilly and Company

Ilker Yalcin

Eli Lilly and Company

Donald Harder

Eli Lilly and Company

John H. Heiligenstein

Eli Lilly and Company

There are several parent- and teacher-scored rating scales that are validated and available for assessing the severity of ADHD symptoms in pediatric populations. However, we are not aware of any symptom severity rating scales with published validation results when administered and scored by clinicians following a semi-structured interview with the parent or guardian.

In a recent clinical trial, in order to have consistency in assessing entry severity criteria and changes in symptom severity over time across patients, we used the ADHD Rating Scale, administered and scored by trained clinicians. Using data from this trial, we assessed the validity and reliability of the ADHD Rating Scale when completed by trained clinicians based on interviews with parents.

Results Indicate that this version of the scale has acceptable levels of inter-rater reliability, test-retest reliability, internal consistency, convergent validity, discriminant validity, and responsiveness. The psychometric properties were comparable to other validated scales for assessing ADHD symptom severity. Overall, this study supports the use of the ADHD Rating Scale as a clinician administered and scored tool for assessing the severity of ADHD symptoms in pediatric patients.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Arch Pediatr Adolesc MedHome page
T. E. Wilens, K. McBurnett, O. Bukstein, J. McGough, L. Greenhill, M. Lerner, M. A. Stein, C. K. Conners, J. Duby, J. Newcorn, et al.
Multisite Controlled Study of OROS Methylphenidate in the Treatment of Adolescents With Attention-Deficit/Hyperactivity Disorder
Arch Pediatr Adolesc Med, January 1, 2006; 160(1): 82 - 90.
[Abstract] [Full Text] [PDF]